183 related articles for article (PubMed ID: 18620576)
1. Dominant negative mutant cyclin T1 proteins inhibit HIV transcription by specifically degrading Tat.
Jadlowsky JK; Nojima M; Schulte A; Geyer M; Okamoto T; Fujinaga K
Retrovirology; 2008 Jul; 5():63. PubMed ID: 18620576
[TBL] [Abstract][Full Text] [Related]
2. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
[TBL] [Abstract][Full Text] [Related]
3. Dominant negative mutant cyclin T1 proteins that inhibit HIV transcription by forming a kinase inactive complex with Tat.
Jadlowsky JK; Nojima M; Okamoto T; Fujinaga K
J Gen Virol; 2008 Nov; 89(Pt 11):2783-2787. PubMed ID: 18931076
[TBL] [Abstract][Full Text] [Related]
4. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.
Garber ME; Mayall TP; Suess EM; Meisenhelder J; Thompson NE; Jones KA
Mol Cell Biol; 2000 Sep; 20(18):6958-69. PubMed ID: 10958691
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of a human cyclin T1 mutant reveals a different binding surface for Tat and HEXIM1.
Kuzmina A; Hadad U; Fujinaga K; Taube R
Virology; 2012 May; 426(2):152-61. PubMed ID: 22342181
[TBL] [Abstract][Full Text] [Related]
6. Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function.
Liou LY; Herrmann CH; Rice AP
J Virol; 2002 Nov; 76(21):10579-87. PubMed ID: 12368300
[TBL] [Abstract][Full Text] [Related]
7. Specific HIV-1 TAR RNA loop sequence and functional groups are required for human cyclin T1-Tat-TAR ternary complex formation.
Richter S; Cao H; Rana TM
Biochemistry; 2002 May; 41(20):6391-7. PubMed ID: 12009901
[TBL] [Abstract][Full Text] [Related]
8. Cyclin T1 stabilizes expression levels of HIV-1 Tat in cells.
Imai K; Asamitsu K; Victoriano AF; Cueno ME; Fujinaga K; Okamoto T
FEBS J; 2009 Dec; 276(23):7124-33. PubMed ID: 20064163
[TBL] [Abstract][Full Text] [Related]
9. Additive activity between the trans-activation response RNA-binding protein, TRBP2, and cyclin T1 on HIV type 1 expression and viral production in murine cells.
Battisti PL; Daher A; Bannwarth S; Voortman J; Peden KW; Hiscott J; Mouland AJ; Benarous R; Gatignol A
AIDS Res Hum Retroviruses; 2003 Sep; 19(9):767-78. PubMed ID: 14585207
[TBL] [Abstract][Full Text] [Related]
10. Cyclin T1 expression is mediated by a complex and constitutively active promoter and does not limit human immunodeficiency virus type 1 Tat function in unstimulated primary lymphocytes.
Martin-Serrano J; Li K; Bieniasz PD
J Virol; 2002 Jan; 76(1):208-19. PubMed ID: 11739686
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel inhibitors of human immunodeficiency virus type 1 replication by in silico screening targeting cyclin T1/Tat interaction.
Hamasaki T; Okamoto M; Baba M
Antimicrob Agents Chemother; 2013 Mar; 57(3):1323-31. PubMed ID: 23274668
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of human cyclin T1 N-terminal region for human immunodeficiency virus-1 Tat transcriptional activation.
Asamitsu K; Hibi Y; Imai K; Victoriano AF; Kurimoto E; Kato K; Okamoto T
J Mol Biol; 2011 Jul; 410(5):887-95. PubMed ID: 21763494
[TBL] [Abstract][Full Text] [Related]
13. A single point mutation in cyclin T1 eliminates binding to Hexim1, Cdk9 and RNA but not to AFF4 and enforces repression of HIV transcription.
Kuzmina A; Verstraete N; Galker S; Maatook M; Bensaude O; Taube R
Retrovirology; 2014 Jul; 11():51. PubMed ID: 24985467
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HIV-1 transcription and replication by a newly identified cyclin T1 splice variant.
Gao G; Wu X; Zhou J; He M; He JJ; Guo D
J Biol Chem; 2013 May; 288(20):14297-14309. PubMed ID: 23569210
[TBL] [Abstract][Full Text] [Related]
15. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.
Fujinaga K; Irwin D; Geyer M; Peterlin BM
J Virol; 2002 Nov; 76(21):10873-81. PubMed ID: 12368330
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1.
Zhang J; Tamilarasu N; Hwang S; Garber ME; Huq I; Jones KA; Rana TM
J Biol Chem; 2000 Nov; 275(44):34314-9. PubMed ID: 10944537
[TBL] [Abstract][Full Text] [Related]
17. Tat acetylation modulates assembly of a viral-host RNA-protein transcription complex.
D'Orso I; Frankel AD
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3101-6. PubMed ID: 19223581
[TBL] [Abstract][Full Text] [Related]
18. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein.
Garber ME; Wei P; KewalRamani VN; Mayall TP; Herrmann CH; Rice AP; Littman DR; Jones KA
Genes Dev; 1998 Nov; 12(22):3512-27. PubMed ID: 9832504
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes.
Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
J Virol; 1999 Jul; 73(7):5777-86. PubMed ID: 10364329
[TBL] [Abstract][Full Text] [Related]
20. Deubiquitinating Enzyme USP21 Inhibits HIV-1 Replication by Downregulating Tat Expression.
Gao W; Li G; Zhao S; Wang H; Huan C; Zheng B; Jiang C; Zhang W
J Virol; 2021 Jun; 95(13):e0046021. PubMed ID: 33827943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
